Navigation Links
Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies

Prime Therapeutics recommends clinical utilization management programs

ST. PAUL, Minn., April 10, 2007 /PRNewswire/ -- Pharmacy benefit manager Prime Therapeutics (Prime) today announced the results of a study on the utilization of Strattera(R) (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children. The study found that children who start on Strattera were 4.2 times more likely to change their therapy than children who started on stimulants. Due to these results and unique Strattera safety concerns, Prime has developed programs that promote the use of a stimulant drug prior to the use of Strattera. The results of this study will be presented at the 19th Annual American Managed Care Pharmacy (AMCP) Conference on April 13 in San Diego.

Because of Prime's close working relationship with many large health plans, Prime is uniquely positioned to analyze both pharmaceutical and medical data to closely monitor drug safety, efficacy, costs and prescribing practices. Prime pays close attention to the ADHD drug category because of safety concerns and the prevalent use of these drugs for treatment of children.

Prime's study involved the integration of medical and pharmacy claims for children in 2004 and 2005 from one Blue Cross and Blue Shield Plan with 1.8 million members. The study analyzed the use of Strattera and stimulants in children to determine how often children switched therapies. Strattera was found to be the first drug tried in one out of five children newly initiating therapy. The results showed that children who start on Strattera were 4.2 times more likely to subsequently change therapy than children who started on stimulants.

"We believe that children who start on Strattera are more likely to change therapies because they are experiencing side effects or the drug is not working effectively," said Patrick Gleason, PharmD, Director of Pharmacy and Medical I
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/31/2014)... 2014 MarketResearchreports.biz presents this most ... (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and ... and Forecast (Value and Volume), 2013 - 2019: Market ... growing at an exponential rate worldwide, has become a ... major cause of death of people between 20 years ...
(Date:7/30/2014)... July 30, 2014 Advanced Photonix ® (NYSE ... 27, 2014) financial results on Monday, August 11, 2014. A ... the close of the market and the Company will host ... 4:30 p.m. EDT on the same day. Participating ... and Director), Rob Risser (COO and Director), and ...
(Date:7/30/2014)... CryoLife, Inc. (NYSE: CRY), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2014 of $0.03 per share of common stock ... will be paid on September 19, 2014 to all ... The ex-dividend date for the quarterly dividend is September ...
Breaking Medicine Technology:The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 2The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 3The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 4The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 5The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 6The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 7The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 8Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3
... (Nasdaq: ARAY ), a global leader in the ... America,s region thereby establishing regionalized management and operational oversight ... of this new Americas region, along with the already ... region control of revenue and profitability and responsibility for ...
... Oct. 21 Flextronics (Nasdaq: FLEX ) is ... agreement to acquire Slomedical S.R.O through a share purchase ... medical devices ranging from tubing sets to complex devices ... before the end of the calendar year, pending required ...
Cached Medicine Technology:Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3Flextronics Announces Expansion of Medical Disposables Offering 2
(Date:7/31/2014)... 2014 Quincy Bioscience, a fast-growing biotech ... supplement Prevagen®, releases the second edition of the Making ... Making Memories: Birth of a Grandchild. , The ... memory-making tips and ideas for grandparents to utilize during ... grandchild. Each concept published in the e-book is free ...
(Date:7/31/2014)... 2014 FORT LAUDERDALE, FLORIDA – ... leading US Joint Commission Accredited teleradiology and telemedicine ... technologically advanced consumer storage and sharing platform for ... providing valued members the use of its Cloud-based ... already offered by SecondOpinions.com®. , Wide-spread radiologic ...
(Date:7/31/2014)... During an annual summer didactic and live technique ... plastic surgeon and a member of the faculty ... of facial anatomy and key advances in facial cosmetic ... Meeting of the Cosmetic Bootcamp included lectures, anatomical analysis, ... principles in modern facial surgery. , One of Dr. ...
(Date:7/31/2014)... Fort Lauderale, FL (PRWEB) July 31, 2014 ... is accepting referrals of insurance patients seeking massage therapy ... The company provides an option for Licensed Massage Therapists ... to refer these patients to BWT. Should a patient ... made the referral, BWT can then contract the therapist ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cheerag ... experienced, sub-specialty trained neurosurgeons at the Saint Luke’s ... Spine Program and director of spine surgery. He comes ... Wash. , “Dr. Upadhyaya has been recognized for his ... complex spine issues. His addition to the Saint Luke’s ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 2Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 3Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 2Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 4
... that Leishmania parasite utilizes mannose for their metabolism// and ... ,Associate Professor Malcolm McConville and his research team ... found a break thorough to control the spread of ... to utilize sugar mannose in the blood for their ...
... tempting red color of strawberries may be the culprit for ... summer fruit, Swedish researchers say., ,"The allergen is in ... it is not clear exactly how. We need to investigate ... was quoted in the magazine Chemistry World, the publication of ...
... blood pressure is well known, however// a new study reports ... published today in the Open Access journal Environmental Health for ... of salt particles can have just the same effect on ... an occupational health hazard for workers in salt factory. It ...
... and co-workers from the Medical Oncology of Yale School// ... that expression of high levels of TRAIL-R2 causes a ... ,TRAIL receptors are cell surface receptors that triggers ... was not associated with survival, high TRAIL-R2 expression strongly ...
... research carried out so far into the effects// of CoQ10 ... new phase III trial is scheduled to commence this year. ... causing soaring prices and reports of fake products entering the ... triggered by the publication of Shults’ earlier phase II study, ...
... severely affect brain functions like learning and impulsive behavior.// ... issue of New Scientist, said that it would help shed ... ,Neuroscientists Yuriori Goto and his team at the University ... the two different regions of the brain in a group ...
Cached Medicine News:Health News:Metabolism cycle of Kala-Azar parasite revealed 2Health News:Hypertension can be caused by Inhalation of Salt 2Health News:Hypertension can be caused by Inhalation of Salt 3Health News:New Discovery to Increase Survival of Breast cancer Patients 2Health News:New Study to look at the Beneficial Effects of Coenzyme Q10 on Parkinson’s disease 2Health News:Regular Use Of Cocaine Can Impair Brain Functions 2
PremierEdge Stab Knives - 30....
... for the total eye. Whether used ... mode or set independently to accommodate ... settings are adjustable to accommodate maximizing ... for use with tonometer-mounted, hand-held and ...
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: